Treatment with mesenchymal stromal cells is a risk factor for pneumonia-related death after allogeneic hematopoietic stem cell transplantation

Hematopoietic Stem Cell Transplantation: An Overview of Infection Risks and Epidemiology

(2011) John R. Wingard et al.   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3-dioxygenase

(2011) R Meisel et al.   LEUKEMIA

Mesenchymal Stem Cells Inhibit Thymic Reconstitution After Allogeneic Cord Blood Transplantation

(2011) Michael Uhlin et al.   STEM CELLS AND DEVELOPMENT

Human mesenchymal stem cells suppress chronic airway inflammation in the murine ovalbumin asthma model

(2010) Tracey L. Bonfield et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT

(2010) O Blennow et al.   BONE MARROW TRANSPLANTATION

Second allogeneic hematopoietic stem cell transplantation: a treatment for graft failure

(2010) Mats Remberger et al.   CLINICAL TRANSPLANTATION

Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients

(2010) Per Ljungman et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Antibacterial Effect of Human Mesenchymal Stem Cells Is Mediated in Part from Secretion of the Antimicrobial Peptide LL-37

(2010) Anna Krasnodembskaya et al.   STEM CELLS

Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses

(2008) H. Karlsson et al.   BLOOD

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES